Differential Expression of sst1, sst2A, and sst 3 Somatostatin Receptor Proteins in Low-Grade and High-Grade Astrocytomas

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 1, 2004, Pages 13-19

  Mawrin, Christian ^a   Schulz, Solveig ^a   Pauli, Steffen U ^a   Treuheit, Tim ^a   Diete, Sabine ^a   Dietzmann, Knut ^a   Firsching, Raimund ^a   Schulz, Stefan ^a   Höllt, Volker ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Astrocytoma; Immunohistochemistry; Somatostatin receptor

Indexed keywords

KI 67 ANTIGEN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR TYPE 1; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; GLIOBLASTOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INTRACRANIAL TUMOR; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; BIOSYNTHESIS; BRAIN TUMOR; COMPARATIVE STUDY; METABOLISM; MORTALITY; PATHOLOGY;

ASTROCYTOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; RECEPTORS, SOMATOSTATIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0348050035     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.1.13     Document Type: Article

References (23)

1. Lamberts SW. Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991;12:450-82
2. Bell GI, Reisine T. Molecular biology of somatostatin receptors. Trends Neurosci 1993;16:34-38
3. Allen JP, Canty AJ, Schulz S, Humphrey PP, Emson PC, Young HM. Identification of cells expressing somatostatin receptor 2 in the gastrointestinal tract of Sstr2 knockout/lacZ knockin mice. J Comp Neurol 2002;454:329-40
4. Schindler M, Humphrey PP, Lohrke S, Friauf E. Immunohistochemical localization of the somatostatin sst2(b) receptor splice variant in the rat central nervous system. Neuroscience 1999;90:859-74
5. Schulz S, Schmidt H, Handel M, Schreff M, Hollt V. Differential distribution of alternatively spliced somatostatin receptor 2 isoforms (sst2A and sst2B) in rat spinal cord. Neurosci Lett 1998;257: 37-40
6. Patel YC, Srikant CB. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 1994;135:2814-17
7. Reubi JC, Lang W, Maurer R, Koper JW, Lamberts SW. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res 1987;47: 5758-64
8. Reubi JC, Maurer R, von Werder K, Torhorst J, Klijn JG, Lamberts SW. Somatostatin receptors in human endocrine tumors. Cancer Res 1987;47:551-58
9. Schulz S, Pauli SU, Schulz S, Handel M, Dietzmann K, Firsching R, Hollt V. Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res 2000;6: 1865-74
10. Zulch KJ. Brain tumors. Their biology and pathology. 3 ed. Berlin-Heidelberg: Springer, 1986
11. Burger PC, Green SB. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 1987; 59:1617-25
12. Ganju V, Jenkins RB, O'Fallon JR, et al. Prognostic factors in gliomas. A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers. Cancer 1994;74:920-27
13. Merlo A, Hausmann O, Wasner M, et al. Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phel-Tyr3-octreotide (DOTATOC): A pilot study in human gliomas. Clin Cancer Res 1999;5:1025-33
14. Dutour A, Kumar U, Panetta R, et al. Expression of somatostatin receptor subtypes in human brain tumors. Int J Cancer 1998;76: 620-27
15. Feindt J, Becker I, Blomer U, et al. Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas. J Neurochem 1995;65:1997-2005
16. Cervera P, Videau C, Viollet C, et al. Comparison of somatostatin receptor expression in human gliomas and medulloblastomas. J Neuroendocrinol 2002;14:458-71
17. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993;3:255-68
18. Schulz S, Schulz S, Schmitt J, et al. Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies. Clin Cancer Res 1998;4:2047-52
19. Schreff M, Schulz S, Handel M, et al. Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain. J Neurosci 2000;20:3785-97
20. Reubi JC, Horisberger U, Lang W, Koper JW, Braakman R, Lamberts SW. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors. Am J Pathol 1989;134:337-44
21. Hirota N, Matsumoto K, Iida M, Sakagami H, Takeda M. Expression of somatostatin messenger RNA and receptor in cultured brain tumor cells. Anticancer Res 1998;18:3295-97
22. Reubi JC, Schaer JC, Laissue JA, Waser B. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism 1996;45:39-41
23. Jaros E, Perry RH, Adam L, et al. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer 1992;66:373-85